Atherosclerotic Cardiovascular Disease

>

Latest News

Digitial illustration of lipid disorders in the blood stream. | Credit: Fotolia
Zerlasiran Further Cements Lp(a)-Lowering Potential in Phase 2 ALPACAR-360 Trial

March 18th 2024

Silence Therapeutics' announcement of topline data from the ALPACAR-360 trial shows promising results for zerlasiran in reducing Lp(a) levels.

Women with Depression Have Greater Cardiovascular Risk Than Men
Women with Depression Have Greater Cardiovascular Risk Than Men

March 12th 2024

US FDA logo | Credit: US Food and Drug Administration
FDA Approves AGENT DCB for In-Stent Restenosis

March 1st 2024

Experts' Perspectives: Top Issue Facing Cardiology in 2024
Experts' Perspectives: Top Issue Facing Cardiology in 2024

February 21st 2024

Cardiology Month in Review Thumbnail. January 2024
Cardiology Month in Review: January 2024

February 6th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.